Figure 4From: Impact of mineral and bone disorder on healthcare resource use and associated costs in the European Fresenius medical care dialysis population: a retrospective cohort study Days of treatment with SHPT-related medications by baseline SHPT parameters, all 10 countries. iPTH, intact parathyroid hormone. *Mean during 3-month baseline period.Back to article page